Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: chief complaint: right hip pain, failure to thrive major surgical or invasive procedure: right hip hemi-arthroplasty with a tumor prosthesis on history of present illness: 69 m with history of renal cell ca, with lung mets who underwent a resection of a giant lytic lesion of the right hip (im nailing of impending right proximal femur pathologic fracture on ). he initially went home after procedure, but had pain in the hip for months. he had pain and difficulty walking after discharge, but did not seek follow up care until when his r hip was found to be infected; he was admitted for debridement of wound. he was discharged home on nafcillin. he was then re-admitted on for failure to thrive, n/v fatigue. since his most recent discharge, he had increasing pain while working with pt and failure to thrive. he was initially admitted to the oncology service. following admission and radiographic evaluation, he was found to have a fracture around the cephalomedullary femoral nail. he was then admitted to the orthopaedic service following surgical intervention for this condition. past medical history: - right nephrectomy and adrenalectomy in - renal cell carcinoma found by bx of mediastenal mass in . metastatic to bone and thorax - left adrenalectomy in - pustular psoriasis - asthma - htn social history: he lives with his wife in , . his daughter is very much involved in his care. he is a former smoker, quit about 24 years ago. he smoked roughly 2 packs per day when he was a smoker. he does not drink alcohol. family history: noncontributory physical exam: pe: elderly man, nad. vs: 97.6 78 145/64 16 96%ra heent: eomi. perrl. mmm. op clear. cv: rrr pulm: poor air movement, otherwise catb abd: obese, soft, nt/nd ext: r hip: incision with staples in place. no erythema. incision site benign. neurovascularly intact distally. pertinent results: 03:30pm pt-13.2* ptt-31.6 inr(pt)-1.2* 03:30pm plt count-180 03:30pm anisocyt-1+ poikilocy-1+ microcyt-1+ 03:30pm neuts-75.1* lymphs-13.8* monos-5.7 eos-4.8* basos-0.6 03:30pm wbc-7.4 rbc-3.74* hgb-10.9* hct-32.2* mcv-86 mch-29.1 mchc-33.8 rdw-16.9* 03:30pm tsh-2.1 03:30pm albumin-3.5 calcium-10.4* phosphate-3.7 magnesium-2.1 03:30pm alt(sgpt)-14 ast(sgot)-19 alk phos-72 tot bili-0.6 03:30pm estgfr-using this 03:30pm glucose-108* urea n-21* creat-1.4* sodium-137 potassium-4.0 chloride-101 total co2-25 anion gap-15 07:30am blood wbc-7.0 rbc-3.08* hgb-9.3* hct-26.3* mcv-85 mch-30.4 mchc-35.6* rdw-15.8* plt ct-107* xray: right tumor prosthesis hip arthroplasty, intact, reduced, well aligned. no fractures. brief hospital course: he was admitted for the reasons indicated above. he underwent right hemi hip arthoplasty with a tumor prosthesis for treatment of his peri-prosthetic fracture. his post-operative course was remarkable for a prolonged intubation for respiratory failure. he was extubated on or around post-operative day number one. the remainder of his hospital course was unremarkable. he worked with physical therapy, weight bearing as tolerated and was discharged to rehab in stable condition on post-operative day number seven. medications on admission: fludrocortisone 0.1 mg qday atenolol 25 mg qday advair diskus 100-50 mcg albuterol prn prednisone 5 mg tablet qday enoxaparin 30 mg/0.3 ml discharge medications: 1. bisacodyl 5 mg tablet, delayed release (e.c.) sig: two (2) tablet, delayed release (e.c.) po daily (daily) as needed. tablet, delayed release (e.c.)(s) 2. ranitidine hcl 150 mg tablet sig: one (1) tablet po bid (2 times a day). 3. simethicone 80 mg tablet, chewable sig: one (1) tablet, chewable po qid (4 times a day) as needed. 4. lactulose 10 g/15 ml syrup sig: thirty (30) ml po q8h (every 8 hours) as needed. 5. insulin regular human 100 unit/ml solution sig: injection asdir (as directed). 6. albuterol 90 mcg/actuation aerosol sig: 1-2 puffs inhalation q6h (every 6 hours) as needed. 7. fludrocortisone 0.1 mg tablet sig: 0.1 tablet po daily (daily). 8. senna 8.6 mg tablet sig: one (1) tablet po bid (2 times a day) as needed. 9. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day). 10. oxycodone 20 mg tablet sustained release 12 hr sig: one (1) tablet sustained release 12 hr po q12h (every 12 hours). 11. metoprolol tartrate 25 mg tablet sig: one (1) tablet po bid (2 times a day). 12. prednisone 10 mg tablet sig: one (1) tablet po daily (daily). 13. enoxaparin 30 mg/0.3 ml syringe sig: 30 mg subcutaneous q12h (every 12 hours) for 6 weeks. 14. hydromorphone 2 mg/ml syringe sig: 0.5-1 mg injection q2h (every 2 hours) as needed for pain. discharge disposition: extended care facility: & rehab center - discharge diagnosis: metastatic renal cell carcinoma. pathologic fracture of the right femur. discharge condition: hemodynamically stable discharge instructions: during this admission you have been treated for metastatic renal cell cancer and a pathologic fracture of the right femur. please continue to take all medications as prescribed. seek immediate medical care if you develop increasing pain, new shortness of breath or chest pain, change in mental status or any other concerning symptoms. followup instructions: change dressings once a day until staples removed 14 days after surgery. keep incision site clean and dry until staples are removed, then may shower. do not soak in bathtub for 1 month. procedure: partial hip replacement local excision of lesion or tissue of bone, femur diagnoses: unspecified essential hypertension asthma, unspecified type, unspecified malignant neoplasm of kidney, except pelvis secondary malignant neoplasm of lung secondary malignant neoplasm of bone and bone marrow pathologic fracture of neck of femur 

Answer: The patient is high likely exposed to